Insider · CIK 0001755314
Roy E Stevens
presidentofficer
Files at LDOS (Leidos Holdings, Inc.). First filing Nov 14, 2024, latest Nov 14, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $229k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LDOS: Leidos Holdings, Inc.
LDOSOct 9, 2026 · close 121.68
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Leidos Holdings, Inc. | $229k 1,137 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | LDOS Leidos Holdings, Inc. | AGrant or award Common Stockindirect: By Key Executive Stock Deferral Plan | +6 | $0.00 | $0 | 1,812 | 9 d ago |
| Nov 12, 2024 | LDOS Leidos Holdings, Inc. | MOption exercise Common Stock | +3,000 | $62.43 | $187k | 47,149 | Nov 14, 2024 |
| Nov 12, 2024 | LDOS Leidos Holdings, Inc. | FTax withholding Common Stock | -1,863 | $201.39 | $375k | 45,286 | Nov 14, 2024 |
| Nov 12, 2024 | LDOS Leidos Holdings, Inc. | SOpen-market sale Common Stock | -1,137 | $201.60 | $229k | 44,149 | Nov 14, 2024 |
| Nov 12, 2024 | LDOS Leidos Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 7,536 | Nov 14, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.